Key result
The A1166C polymorphism in the AT1 gene showed no relationship with acute stroke in the Turkish population, with a C allele frequency of 3% in patients versus 8% in healthy controls.
Why the study?
Does the A1166C polymorphism in the AT1 gene associate with acute stroke development in the Turkish population?
Case-Control (n=257)
Does the A1166C polymorphism in the AT1 gene associate with acute stroke development in the Turkish population?
Absolute Event Rate: 3% vs 8%
p-value: p=<0.001
The A1166C polymorphism in the AT1 gene does not appear to be associated with the development of acute stroke in the Turkish population.
No association in this Turkish case-control study; leaves open ethnic variation in AT1 genetic stroke risk.
This study was performed in acute stroke patients in the Turkish population to determine the frequency of the A1166C polymorphism in the AT1 gene and to examine the role of this polymorphism in acute stroke development. In this study, 257 genomic DNA samples were analysed (from 206 acute stroke patients and 51 healthy individuals). Genomic DNA was prepared from peripheral blood using the salt-extraction method. The presence of the A1166C polymorphism in the AT1 gene was determined using the polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method. PCR products were separated by 2% agarose gel electrophoresis and visualized by a charge-coupled device (CCD) camera. In this study, the allele frequency at the A1166C position was 92% A and 8% C for control and 97% A and 3% C for patients. This difference in allele frequency between the control group and the patient group was not statistically significant. However, genotype and allele frequencies showed a significant difference (P < 0.001) in the control and the patient groups. The results of this study show no relationship between the A1166C polymorphism in the AT1 gene and acute stroke in the Turkish population.
No takes yet. Share an insight, caveat, or question.
Kurt et al. (2013) conducted a case-control in Acute stroke (n=257). A1166C polymorphism in the AT1 gene vs. Healthy individuals was evaluated on Allele frequency of the A1166C polymorphism in the AT1 gene (p=<0.001). The A1166C polymorphism in the AT1 gene showed no relationship with acute stroke in the Turkish population, with a C allele frequency of 3% in patients versus 8% in healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: